FDA holds back from action over Xeljanz safety studyThe FDA has said it will wait for additional results from last week’s trial showing an increased risk Share XFDA holds back from action over Xeljanz safety studyhttps://pharmaphorum.com/news/fda-holds-back-from-action-over-xeljanz-safety-study/
Bad news for Pfizer as blockbuster Xeljanz flunks safety studyJAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and Share XBad news for Pfizer as blockbuster Xeljanz flunks safety studyhttps://pharmaphorum.com/news/bad-news-for-pfizer-as-blockbuster-xeljanz-flunks-safety-study/
Coronavirus vaccine may have allergy warning in US, says expertThe US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should Share XCoronavirus vaccine may have allergy warning in US, says experthttps://pharmaphorum.com/news/coronavirus-vaccine-may-have-allergy-warning-in-us-says-expert/
FDA puts Bellicum’s cancer cell therapy trial on holdThe FDA has placed a clinical hold on a phase 1/2 trial of Bellicum’s cancer cell therapy BPX-601, Share XFDA puts Bellicum’s cancer cell therapy trial on holdhttps://pharmaphorum.com/news/fda-puts-bellicums-cancer-cell-therapy-trial-on-hold/
AZ’s COVID-19 vaccine trial ready to resume in US – reportsAstraZeneca’s COVID-19 vaccine trial could be ready to resume this week in the US after a seven-week hiatus Share XAZ’s COVID-19 vaccine trial ready to resume in US – reportshttps://pharmaphorum.com/news/azs-covid-19-vaccine-trial-ready-to-resume-reports/
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDAEli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found Share XLilly pauses COVID-19 antibody trial after factory hits trouble with FDAhttps://pharmaphorum.com/news/lilly-pauses-covid-19-antibody-trial-after-factory-hits-trouble-with-fda/
AZ resumes UK coronavirus vaccine trialAstraZeneca has resumed UK trials for its coronavirus vaccine, after the country’s medicines regulator gave the all-clear following Share XAZ resumes UK coronavirus vaccine trialhttps://pharmaphorum.com/news/az-resumes-uk-coronavirus-vaccine-trial/
WHO halts hydroxychloroquine trial in COVID-19 following safety concernsThe World Health Organisation has halted clinical tests of hydroxychloroquine against COVID-19, after safety concerns emerged in a Share XWHO halts hydroxychloroquine trial in COVID-19 following safety concernshttps://pharmaphorum.com/news/who-halts-hydroxychloroquine-trial-in-covid-19-following-safety-concerns/
EU regulators warn over safety of Trump’s favourite COVID drugsAs the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of Share XEU regulators warn over safety of Trump’s favourite COVID drugshttps://pharmaphorum.com/news/eu-regulators-warn-over-safety-of-trumps-favourite-covid-drug/
